Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes


Peptides can be labeled with various trivalent radiometals for imaging or targeted radionuclide-therapy applications. The peptide is first conjugated to a chelating agent that is able to form stable complexes with the radionuclide of interest. This conjugation step can be carried out as part of the solid-phase peptide synthesis, or it can be undertaken in the solution phase after synthesis and purification of the peptide. The latter route, described here, involves reacting a molar excess of the activated tri-tert-butyl ester-derivatized chelator with a designated free amino group of a peptide analog, in which all other reactive amines are protected, in the presence of a coupling agent. The conjugate molecule is then purified prior to deprotection and further purification by HPLC. The product can be radiolabeled by addition of a suitable metal salt, followed, if necessary, by removal of the unchelated metal. The entire process of conjugation, purification and radiolabeling should take approximately 12.5 h.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: Chemical structures.


  1. Cooper, M.S., Sabbah, E. & Mather, S.J. Conjugation of chelating agents to proteins and radiolabelling with trivalent metallic isotopes. Nat. Protocols, published online 27 June 2006 (doi:10.1038/nprot.2006.49).

  2. Achilefu, S. et al. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors. J. Med. Chem. 46, 3403–3411 (2003).

    Article  CAS  Google Scholar 

  3. Chan, W.C. & White, P.D. (eds.) Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Oxford University Press, Oxford, UK, 2000).

    Google Scholar 

  4. De Leon-Rodriguez, L.M., Kovacs, Z., Dieckmann, G.R. & Sherry, A.D. Solid-phase synthesis of DOTA-peptides. Chemistry 10, 1149–1155 (2004).

    Article  CAS  Google Scholar 

  5. Reubi, J.C. et al. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo. Eur. J. Nucl. Med. 25, 481–490 (1998).

    Article  CAS  Google Scholar 

  6. Edreira, M., Melendez-Alafort, L. & Mather, S.J. Optimization of the small-scale synthesis of DOTA-Tyr3-octreotide. Nucl. Med. Commun. 23, 493–499 (2002).

    Article  CAS  Google Scholar 

  7. Heppeler, A. et al. Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy. Chem. Eur. J. 5, 1974–1981 (1999).

    Article  CAS  Google Scholar 

  8. Breeman, W.A. et al. Radiolabelling DOTA-peptides with 68Ga. Eur. J. Nucl. Med. Mol. Imaging 32, 478–485 (2005).

    Article  CAS  Google Scholar 

  9. Breeman, W.A., De Jong, M., Visser, T.J., Erion, J.L. & Krenning, E.P. Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities. Eur. J. Nucl. Med. Mol. Imaging 30, 917–920 (2003).

    Article  CAS  Google Scholar 

  10. Hainsworth, J.E. & Mather, S.J. Regressive DOTA labelling performance with indium-111 and yttrium-90 over a week of use. Eur. J. Nucl. Med. Mol. Imaging 32, 1348 (2005).

    Article  Google Scholar 

  11. Bio-Rad Laboratories. Chelex 100 and Chelex 20 Chelating Ion Exchange Resin Instruction Manual (Bio-Rad Laboratories, Hercules, CA, 2000).

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Jane K Sosabowski or Stephen J Mather.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sosabowski, J., Mather, S. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes. Nat Protoc 1, 972–976 (2006).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing